Morgan Stanley has projected the weight loss medication market to reach $150 billion globally by 2035. The use of GLP-1s, such as Ozempic, have increased drastically since 2019. At the same time, new research shows that the use of these drugs still comes with the risk of judgement and social pressures that all relate to weight stigma.

An Oregon-based group, Body Liberation for Public Health, wants to help end these stigmas. The group is advocating for body liberation, which is a movement aimed to dismantle the systems that have created weight stigmas and bias, as opposed to the body positivity movement, which encourages acceptance of all body types. Debbie Kaufman is the creator of the project. She joins us to share more on what body liberation is and why it’s important to incorporate it into public health.